Therapeutic Education Using an Internet Application in Hereditary Ichthyosis (e-ETPichtyose)

April 11, 2024 updated by: University Hospital, Toulouse

Evaluation of the Feasibility and Effect of Therapeutic Education Sessions Using an Internet Application in Hereditary Ichthyosis

The main purpose is to evaluate the feasibility (global use) of a therapeutic patient education program using a specific web application in patients with hereditary ichthyosis.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Toulouse, France, 31059
        • CHU Toulouse, Hôpital Larrey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 60 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient with hereditary ichthyosis, according to the classification established during the 2009 consensus conference
  • Who has given his informed consent form
  • Who is affiliated to a social security system

Exclusion Criteria:

  • Patient who has already participated in a therapeutic patient education program for the hereditary ichthyosis
  • Unable to connect or use a computer tool
  • Impossibility to be present at the only face-to-face session
  • Patient who is not available for the collective educational session
  • Patient with little or no motivation to follow a therapeutic patient education program (motivation evaluated by the educational team by phone call before inclusion)
  • Patient not mastering the French language
  • Person under legal protection (guardianship, curators or safeguard of justice)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapeutic Patient Education program
All included patients will follow a Therapeutic Patient Education program dedicated to the hereditary ichthyosis and using a web application, WebIchtyose
WebIchtyose is a specific therapeutic patient education program for patients with hereditary Ichthyosis targeting the problems of each patient by means of a personalized follow-up and a constant interaction between the patient and the educational team
Other Names:
  • WebIchtyose

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global use
Time Frame: 6 months
percentage of patients who have used the "WebIchtyose" application for at least 8 hours during 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fractional use in each domain (educational sessions)
Time Frame: 6 months
"WebIchtyose" application use time by the patient for group and individual educational sessions
6 months
Fractional use in each domain (continuous educational follow-up)
Time Frame: 6 months
"WebIchtyose" application use time by the patient for the continuous educational follow-up
6 months
Fractional use in each domain (consultation)
Time Frame: 6 months
"WebIchtyose" application use time by the patient for the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application
6 months
Fractional use in each domain (questionnaires)
Time Frame: 6 months
"WebIchtyose" application use time by the patient for the filling of the questionnaires
6 months
Fractional use in each domain
Time Frame: 6 months
"WebIchtyose" application use time by the patient for group and individual educational sessions, the continuous educational follow-up, the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application
6 months
Difficulty of individual application registration
Time Frame: Baseline
Difficulty of registration questionnaire completed for each patient jointly by the patient and the educational team at the end of the face-to-face inclusion visit
Baseline
Difficulties of use in everyday life by the patient
Time Frame: 6 months
Questionnaire completed for each patient jointly by the patient at the end of the program
6 months
Number of exchanges
Time Frame: 3 months and 5 months
Number of exchanges necessary between the educational team and the patient to set a date for the conduct of the individual educational sessions
3 months and 5 months
Response time
Time Frame: 6 months
Response time of the educational team following a request from the patient as part of the educational follow-up
6 months
Number of relaunches
Time Frame: 2 months, 4 months and 6 months
How many times the nurse relaunches the patient to obtain the assessment questionnaires
2 months, 4 months and 6 months
Number of non-received questionnaires
Time Frame: 2 months, 4 months and 6 months
Number of non-received questionnaires after relaunch
2 months, 4 months and 6 months
Number of lost to follow-up patients
Time Frame: 9 months
Number of lost to follow-up patients
9 months
Patient acceptability
Time Frame: 6 months
Acceptability questionnaire to be completed by the patient
6 months
Educational team acceptability
Time Frame: 6 months
Acceptability questionnaire to be completed by each member of the educational team
6 months
Attractiveness
Time Frame: 6 months
Application attractiveness questionnaire completed by the patient
6 months
Quality of life before and after treatment
Time Frame: Inclusion, 6 months and 9 months
Quality of life questionnaire for hereditary ichthyosis (IQoL-32)
Inclusion, 6 months and 9 months
Self-assessment of cutaneous severity
Time Frame: Inclusion and 6 months
Self-assessment of cutaneous severity according to an analogic visual scale for pain, pruritus, erythema, squama
Inclusion and 6 months
Knowledge about disease and treatments
Time Frame: Inclusion and 6 months
Questionnaire of knowledge about disease and treatments
Inclusion and 6 months
Self-care skills
Time Frame: Inclusion and 6 months
Questionnaire of self-care skills
Inclusion and 6 months
Self-esteem
Time Frame: Inclusion and 6 months
Questionnaire about self-esteem: Rosenberg scale. For each item of the questionnaire, the modality answers are : 1 (totally disagree), 2 (quite disagree), 3 (quite agree) and 4 (totally disagree). The total score (/ 40) is calculated by adding the scores obtained for each item.
Inclusion and 6 months
Coping scale
Time Frame: Inclusion and 6 months
Coping with health injuries and problem (Endler 1998). For each item of the questionnaire, the modality answers are: 1 (not at all), 2 (a little), 3 (moderately), 4 (often) and 5 (a lot).The total score (/ 160) is calculated by adding the scores obtained for each item.
Inclusion and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juliette Mazereeuw-Hautier, MD, University Hospital, Toulouse

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2018

Primary Completion (Actual)

February 21, 2023

Study Completion (Actual)

February 21, 2023

Study Registration Dates

First Submitted

June 4, 2018

First Submitted That Met QC Criteria

August 17, 2018

First Posted (Actual)

August 21, 2018

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 11, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ichthyosis

Clinical Trials on Therapeutic patient education program

3
Subscribe